Can a Play-Based therapy boost development in babies with down syndrome?

NCT ID NCT07163780

Recruiting now Disease control Sponsor: Izgi Miray Demirbag Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new early intervention called HEP (Homeostasis-Enrichment-Plasticity) for infants with Down syndrome, ages 4 to 12 months. The approach is child-centered and family-based, focusing on enriched environments and brain plasticity. Over 12 sessions, researchers will compare HEP to traditional therapy to see if it improves motor and sensory development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HEP (Homeostasis-Enrichment-Plasticity) behavioral intervention
What this could lead to: If it works, this could offer a new early therapy to help infants with Down syndrome develop better motor and sensory skills.
What could go wrong: This is a small, early-stage study with only 26 infants, so results may not apply to all children. The intervention is behavioral, not a drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DOWN SYNDROME (DS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Down syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DOWN SYNDROME (DS)

Contacts and locations

Locations

Sense On
RECRUITING

Istanbul, Beykoz, 34810, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.